This paper, which had a spike in citations from 2016 to 2020 and directed research direction, discovered that levels of P-S396-tau, P-T181-tau, and Aβ1-42 in extracts of neurally generated blood exosomes might anticipate the progression of AD as long as 10 years before clinical onset. This evidence concerns the gene MAPT and Alzheimer disease.